EcoDrugPlus

Ensembl ID : ENSAPEG00000010265
Gene Symbol: RARGB
1 Cross references
367 Possible Orthologues:

Ensembl ID : ENSAPEG00000011922
Gene Symbol: TIE1
1 Cross references
207 Possible Orthologues:

Ensembl ID : ENSAPEG00000020274
Gene Symbol: -
Cross references: -
142 Possible Orthologues:

Ensembl ID : ENSAPEG00000016926
Gene Symbol: -
Cross references: -
253 Possible Orthologues:

Ensembl ID : ENSAPEG00000005372
Gene Symbol: PSMD11B
1 Cross references
215 Possible Orthologues:

Ensembl ID : ENSAPEG00000014891
Gene Symbol: PSENEN
1 Cross references
185 Possible Orthologues:

Ensembl ID : ENSAPEG00000003553
Gene Symbol: -
Cross references: -
231 Possible Orthologues:

Ensembl ID : ENSAPEG00000014819
Gene Symbol: RPS4X
1 Cross references
497 Possible Orthologues:

Ensembl ID : ENSAPEG00000001519
Gene Symbol: -
Cross references: -
209 Possible Orthologues:

Ensembl ID : ENSAPEG00000000774
Gene Symbol: -
Cross references: -
195 Possible Orthologues:

Ensembl ID : ENSAPEG00000000606
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSAPEG00000017924
Gene Symbol: RPL10
1 Cross references
407 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).